Sotac Pharma.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE0O2D01012
NSEID: SOTAC
BSEID:

INR

129.55

-6.8 (-4.99%)

BSENSE

Dec 05

BSE+NSE Vol: 2400

{
  "main_header": {
    "sid": 1003827,
    "name": "Sotac Pharma.",
    "stock_name": "Sotac Pharma.",
    "full_name": "Sotac Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/sotac-pharma",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "129.55",
    "chg": -6.8,
    "chgp": "-4.99%",
    "dir": -1,
    "prev_price": "136.35",
    "mcapval": "148.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "SOTAC",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0O2D01012",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": 2400,
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sotac-pharma-1003827-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sotac Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-hits-lower-circuit-amid-heavy-selling-pressure-3748952",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SotacPharmaceut_stocks_hitting_lower_circuit_3748952.png",
        "date": "2025-12-05 12:00:07",
        "description": "Sotac Pharmaceuticals Ltd witnessed a sharp decline on 5 Dec 2025, hitting its lower circuit price limit as intense selling pressure gripped the stock. The pharmaceutical and biotechnology company’s shares closed at ₹129.55, marking a maximum daily loss of 4.99%, underperforming both its sector and the broader market indices."
      },
      {
        "title": "Sotac Pharmaceuticals Faces Intense Selling Pressure Amid Market Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3748879",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SotacPharmaceut_only_sellers_3748879.png",
        "date": "2025-12-05 11:36:11",
        "description": "Sotac Pharmaceuticals Ltd experienced a pronounced decline on 5 Dec 2025, with the stock registering a sharp fall of 4.99% in a session dominated exclusively by sell orders. This extreme selling pressure, coupled with the absence of buyers, signals distress selling and highlights the challenges facing the company within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sotac Pharma. Sees Revision in Market Assessment Amid Mixed Evaluation Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sotac-pharma-upgraded-from-strong-sell-to-hold-by-marketsmojo-3746577",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SotacPharma_mojoScore_3746577.png",
        "date": "2025-12-04 11:08:06",
        "description": "Sotac Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market assessment, reflecting shifts across key evaluation parameters. This development comes amid a backdrop of steady stock returns and a complex financial profile, prompting investors to reassess the company’s position within its sector."
      },
      {
        "title": "How has been the historical performance of Sotac Pharma.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-sotac-pharma-3736026",
        "imagepath": "",
        "date": "2025-11-28 22:44:21",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profitability Trends</strong></p>\n<p>Over the five-year period ending March 2025, Sotac Pharma. saw its net sales rise substantially from ₹28.60 crores in 2020 to ₹96.99 crores in 2025. This represents a more than threefold increase, reflecting the company’s expanding market presence and operational scale. However, the revenue peaked in 2024 at ₹103.83 crores before a slight dip in 2025, indicating some volatility in sales performance.</p>\n<p>Operating profit margins have improved markedly, with the operating profit excluding other income increasing from a modest 6.5% margin in 2020 to a robust 14.07% in 2025. This improvement underscores enhanced operational efficiency and cost management. The company’s profit before tax surged from a marginal ₹0.36 crores in 2020 to ₹11.12 cror..."
      },
      {
        "title": "Why is Sotac Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sotac-pharma-fallingrising-3734419",
        "imagepath": "",
        "date": "2025-11-28 00:46:59",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Strong Recent Performance and Market Comparison</strong></p>\n<p>Sotac Pharmaceuticals has demonstrated impressive returns over various time horizons, significantly outpacing benchmark indices. Over the past week, the stock gained 6.40%, compared to a marginal 0.09% rise in the Sensex. The one-month return of 3.50% also surpasses the Sensex’s 0.96%. Year-to-date, the stock has surged 21.68%, nearly doubling the Sensex’s 10.87% gain. Over the last year, Sotac Pharma’s shares have appreciated by 15.65%, almost twice the 7.99% return of the Sensex. These figures highlight the stock’s consistent ability to outperform the broader market, attracting investor interest and confidence.</p>\n<p><strong>Technical Indicators and Investor Activity</strong></p>\n<p>On 27-Nov, Sotac Pharmaceuticals traded abo..."
      },
      {
        "title": "Sotac Pharmaceuticals Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-hits-upper-circuit-amid-strong-buying-pressure-3717637",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SotacPharmaceut_stocks_hitting_upper_circuit_3717637.png",
        "date": "2025-11-20 10:00:27",
        "description": "Sotac Pharmaceuticals Ltd witnessed a significant surge in its share price on 20 Nov 2025, hitting the upper circuit limit of 5.0% to close at ₹131.25. This movement reflects robust buying interest and a notable outperformance relative to its sector and benchmark indices, signalling heightened investor enthusiasm in the Pharmaceuticals & Biotechnology space."
      },
      {
        "title": "Sotac Pharmaceuticals Hits Lower Circuit Limit, Closes at Rs 122.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-hits-lower-circuit-limit-closes-at-rs-12255-3707698",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SotacPharmaceut_stocks_hitting_lower_circuit_3707698.png",
        "date": "2025-11-17 14:00:13",
        "description": "Sotac Pharmaceuticals Ltd faced notable trading activity as its stock reached the lower circuit limit, closing at Rs 122.55. The stock's performance lagged behind the sector, with a total traded volume of 0.024 lakh shares. Its positioning relative to moving averages indicates volatility typical of microcap stocks."
      },
      {
        "title": "Sotac Pharmaceuticals Faces Significant Selling Pressure, Stock Declines 5.00% Amid Ongoing Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-faces-significant-selling-pressure-stock-declines-500-amid-ongoing-losses-3707626",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SotacPharmaceut_only_sellers_3707626.png",
        "date": "2025-11-17 13:05:51",
        "description": "Sotac Pharmaceuticals Ltd is experiencing notable selling pressure, marked by consecutive losses and a significant decline in its stock performance. Over the past month and year, the company has underperformed compared to the Sensex, raising concerns about its longer-term trajectory despite a positive year-to-date performance."
      },
      {
        "title": "How has been the historical performance of Sotac Pharma.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-sotac-pharma-3704212",
        "imagepath": "",
        "date": "2025-11-15 00:29:00",
        "description": "Answer:\nThe historical performance of Sotac Pharma shows a trend of increasing net sales and profitability over the years, with a notable rise in both operating and net profits.\n\nBreakdown:\nSotac Pharma's net sales have shown a steady increase from INR 28.60 crore in March 2020 to INR 96.99 crore in March 2025, despite a slight decline to INR 103.83 crore in March 2024. The total operating income followed a similar trajectory, reaching INR 96.99 crore in March 2025. The company's operating profit (PBDIT) also improved significantly, rising from INR 1.56 crore in March 2021 to INR 17.55 crore in March 2025, reflecting an operating profit margin increase from 2.97% to 14.07% over the same period. Profit before tax surged to INR 11.12 crore in March 2025, up from a loss of INR 2.06 crore in March 2021, while profit after tax reached INR 9.28 crore in March 2025, compared to a loss of INR 2.37 crore in March 20..."
      }
    ],
    "total": 308,
    "sid": "1003827",
    "stock_news_url": "https://www.marketsmojo.com/news/sotac-pharmaceuticals-1003827"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sotac Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sotac Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure

2025-12-05 12:00:07

Sotac Pharmaceuticals Ltd witnessed a sharp decline on 5 Dec 2025, hitting its lower circuit price limit as intense selling pressure gripped the stock. The pharmaceutical and biotechnology company’s shares closed at ₹129.55, marking a maximum daily loss of 4.99%, underperforming both its sector and the broader market indices.

Sotac Pharmaceuticals Faces Intense Selling Pressure Amid Market Downturn

2025-12-05 11:36:11

Sotac Pharmaceuticals Ltd experienced a pronounced decline on 5 Dec 2025, with the stock registering a sharp fall of 4.99% in a session dominated exclusively by sell orders. This extreme selling pressure, coupled with the absence of buyers, signals distress selling and highlights the challenges facing the company within the Pharmaceuticals & Biotechnology sector.

Sotac Pharma. Sees Revision in Market Assessment Amid Mixed Evaluation Metrics

2025-12-04 11:08:06

Sotac Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market assessment, reflecting shifts across key evaluation parameters. This development comes amid a backdrop of steady stock returns and a complex financial profile, prompting investors to reassess the company’s position within its sector.

How has been the historical performance of Sotac Pharma.?

2025-11-28 22:44:21

Revenue and Profitability Trends

Over the five-year period ending March 2025, Sotac Pharma. saw its net sales rise substantially from ₹28.60 crores in 2020 to ₹96.99 crores in 2025. This represents a more than threefold increase, reflecting the company’s expanding market presence and operational scale. However, the revenue peaked in 2024 at ₹103.83 crores before a slight dip in 2025, indicating some volatility in sales performance.

Operating profit margins have improved markedly, with the operating profit excluding other income increasing from a modest 6.5% margin in 2020 to a robust 14.07% in 2025. This improvement underscores enhanced operational efficiency and cost management. The company’s profit before tax surged from a marginal ₹0.36 crores in 2020 to ₹11.12 cror...

Why is Sotac Pharma. falling/rising?

2025-11-28 00:46:59

Strong Recent Performance and Market Comparison

Sotac Pharmaceuticals has demonstrated impressive returns over various time horizons, significantly outpacing benchmark indices. Over the past week, the stock gained 6.40%, compared to a marginal 0.09% rise in the Sensex. The one-month return of 3.50% also surpasses the Sensex’s 0.96%. Year-to-date, the stock has surged 21.68%, nearly doubling the Sensex’s 10.87% gain. Over the last year, Sotac Pharma’s shares have appreciated by 15.65%, almost twice the 7.99% return of the Sensex. These figures highlight the stock’s consistent ability to outperform the broader market, attracting investor interest and confidence.

Technical Indicators and Investor Activity

On 27-Nov, Sotac Pharmaceuticals traded abo...

Sotac Pharmaceuticals Hits Upper Circuit Amid Strong Buying Pressure

2025-11-20 10:00:27

Sotac Pharmaceuticals Ltd witnessed a significant surge in its share price on 20 Nov 2025, hitting the upper circuit limit of 5.0% to close at ₹131.25. This movement reflects robust buying interest and a notable outperformance relative to its sector and benchmark indices, signalling heightened investor enthusiasm in the Pharmaceuticals & Biotechnology space.

Sotac Pharmaceuticals Hits Lower Circuit Limit, Closes at Rs 122.55

2025-11-17 14:00:13

Sotac Pharmaceuticals Ltd faced notable trading activity as its stock reached the lower circuit limit, closing at Rs 122.55. The stock's performance lagged behind the sector, with a total traded volume of 0.024 lakh shares. Its positioning relative to moving averages indicates volatility typical of microcap stocks.

Sotac Pharmaceuticals Faces Significant Selling Pressure, Stock Declines 5.00% Amid Ongoing Losses

2025-11-17 13:05:51

Sotac Pharmaceuticals Ltd is experiencing notable selling pressure, marked by consecutive losses and a significant decline in its stock performance. Over the past month and year, the company has underperformed compared to the Sensex, raising concerns about its longer-term trajectory despite a positive year-to-date performance.

How has been the historical performance of Sotac Pharma.?

2025-11-15 00:29:00

Answer: The historical performance of Sotac Pharma shows a trend of increasing net sales and profitability over the years, with a notable rise in both operating and net profits. Breakdown: Sotac Pharma's net sales have shown a steady increase from INR 28.60 crore in March 2020 to INR 96.99 crore in March 2025, despite a slight decline to INR 103.83 crore in March 2024. The total operating income followed a similar trajectory, reaching INR 96.99 crore in March 2025. The company's operating profit (PBDIT) also improved significantly, rising from INR 1.56 crore in March 2021 to INR 17.55 crore in March 2025, reflecting an operating profit margin increase from 2.97% to 14.07% over the same period. Profit before tax surged to INR 11.12 crore in March 2025, up from a loss of INR 2.06 crore in March 2021, while profit after tax reached INR 9.28 crore in March 2025, compared to a loss of INR 2.37 crore in March 20...

View All News